The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025 Annual Conference & secures finalist status in the ‘Best Contract Research Organization– Specialist Providers’ category at the SCRIP Awards
King of Prussia, PA – October 7th, 2025: CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.
At the 2025 SCDM Annual Conference, CluePoints was recognized for its Intelligent Query Detection (IQD) solution, built in collaboration with a top global pharmaceutical partner. The AI-driven solution transforms how clinical trial data is reviewed and cleaned by automating data discrepancy detection, query generation, and review workflows. This reduces manual effort, cutting review times by more than 60%, and achieving over 95% accuracy.
CluePoints’ SCRIP finalist position further reflects the company’s commitment to addressing long-standing challenges in clinical data review. By expanding its platform with innovations such as Medical & Safety Review (MSR) and the Time Similarity Test (TST) (to pinpoint data anomalies that would previously go undetected), CluePoints has helped sponsors detect anomalies earlier, simplify medical oversight, and elevate patient safety, empowering trial teams to make faster, more reliable decisions.
Speaking on the shortlist announcement, Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, commented: “The SCDM Innovation Award win and SCRIP Award shortlist announcement are a testament to the hard work of the whole CluePoints team. It is always an honor to be to be recognized by our peers alongside so many industry leaders. Better data interrogation and review is the essence of the CluePoints brand. We believe every algorithm and insight is a conduit for delivering real, tangible advantages to our customers. By aligning talented people, the right processes and the right technology, we can optimize clinical trials and develop innovative therapies that benefit patients globally.”
The winners of all categories of the 21st annual SCRIP Awards will be announced at a ceremony on Thursday, 11th December 2025 at the London Hilton on Park Lane.
To learn more about CluePoints’ award-winning solutions, please visit www.cluepoints.com
About CluePoints
CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of Artificial Intelligence using Advanced Statistics and Machine Learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R3), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.
Media Contact
Jodie Dixon – Discovery PR, on behalf of CluePoints
Email: [email protected]
Mobile: +44 (0)7507 727721
Office: +44 (0) 1606 889 194
